FASEB J.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by FADEEL, B.
Right arrow Articles by PERVAIZ, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FADEEL, B.
Right arrow Articles by PERVAIZ, S.
(The FASEB Journal. 2004;18:1-4.)
© 2004 FASEB

Buried alive: a novel approach to cancer treatment

BENGT FADEEL, STEN ORRENIUS and SHAZIB PERVAIZ*,1

Institute of Environmental Medicine, Division of Toxicology, Karolinska Institutet, Stockholm, Sweden; and
* NUS Graduate School of Integrative Sciences and Engineering, and Department of Physiology, Faculty of Medicine, National University of Singapore, Singapore

1Correspondence: NUS Graduate School of Integrative Sciences and Engineering, Department of Physiology, Faculty of Medicine, National University of Singapore, MD9 #03-06, Singapore. E-mail: phssp{at}nus.edu.sg

ABSTRACT

The heightened interest in the development of novel anti-cancer drugs that trigger apoptotic death in cancer cells stems from the fact that immediately upon execution of the death signal, the corpse is efficiently removed via specific recruitment of phagocytic cells. This prevents spilling of cellular contents and the associated inflammatory response, a likely scenario during necrotic death. Recent evidence has established that phagocytic removal of apoptotic cells is a function of ligand–receptor interaction, whereby the ligand(s) for the scavenger receptor(s) of phagocytic cells is/are specifically expressed on apoptosing cells. Therefore, by implication, enhancing this ligand–receptor interaction could be an alternate means for removing unwanted cells. Here we present a provocative hypothesis that circumvents the need for chemotherapy-induced apoptosis in cancer cells. According to our model, cancer cells need not die in order to be removed by scavenger cells, but could still be effectively phagocytosed provided the cell surface expression of specific molecules that strongly engage phagocytic cells is sufficiently enhanced. In other words, inducing the expression of "eat me" signals on cancer cells could be a novel approach to "bury alive" these unwanted cells without the untoward effects of chemotherapy-induced apoptosis.—Fadeel, B., Orrenius, S., Pervaiz, S. Buried alive: a novel approach to cancer treatment.


Key Words: cancer cells • apoptosis • scavenger receptors • phagocytosis • cell clearance







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The Federation of American Societies for Experimental Biology.